IL6 and Obesity: Targeting IL-6 systemically constitutes a treatment strategy for inflammation-mediated diseases including diabetes, obesity and rheumatoid arthritis.24 Systemically altered IL-6 may play a role in malnourishment pathophysiology,25 and its levels in the circulation are also controlled by genetic polymorphisms.